Rebalix
Logo iSharesiShares · sheet of 10 September 2026
ETF sheet · official issuer and register data

iShares Dow Jones Industrial Average UCITS ETF

CIND · IE00B53L4350 · USD · domicile Ireland
Equity · United States · Industrials · Large capSFDR art. 6
Index tracked: Dow Jones Industrial Average Net TR (USD)
TER
0.33%+ trans. 0.01%
Fund size
1.7 bn EUR
Tracking difference
−0.06%3-year avg
🇮🇹 tax rate
26.00%white list 0.00%
Replication
Physical
Income
Accumulating
Launch 26 Jan 2010 · costs from the KID as of 2 Sept 2026 · 30 securities held · 8 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 4 Aug 2026
The Fund is a share class of a Fund which aims to achieve a return on your investment, through a combination of capital growth and income on the Fund’s assets, which reflects the return of the Dow Jones Industrial Average Index, the Fund’s benchmark index (Index). The Fund, via the Fund is passively managed and aims to invest so far as possible and practicable in the equity securities (e.g. shares) that make up the Index. The Index measures the performance of equity securities issued by 30 large and well known US companies that cover all industries…

Performance since series start (in euro) — base 100

26 Jan 201031 Aug 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
201120142017202020232026844100828
High 844 (7 Aug 2026) · low 100 (26 Jan 2010) · last 828. Past performance is not indicative of future results.

Returns in euro

1 year+18.5%
3 years+48.4%
5 years+62.0%
10 years+220.6%
Since series start+727.5%

Risk · 1 / 3 / 5 years

Volatility (ann.)12.49%13.46%14.75%
Max drawdown−9.81%−16.09%−21.10%
Sharpe1.140.950.54
Sortino1.701.420.79
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · CIND · IE00B53L43501
RebalixCIND · IE00B53L4350 · sheet of 10 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · from issuer-declared series
YearFundIndexTD
2025+14.25%+14.33%−0.08%
2024+14.28%+14.35%−0.07%
2023+15.42%+15.43%−0.02%
2022−7.45%−7.44%+0.00%
2021+20.18%+20.28%−0.10%

Holdings

Portfolio as declared by the issuer · 31 Aug 2026 · 30 securities · top-10 weight = 55.0%
Top holdingsWeight
GOLDMAN SACHS GROUP11.4%
CATERPILLAR INC8.9%
MICROSOFT5.7%
AMGEN INC4.8%
UNITEDHEALTH GROUP INC4.3%
VISA CLASS A4.2%
TRAVELERS COMPANIES4.1%
JPMORGAN CHASE & CO4.0%
ALPHABET CLASS A3.8%
SHERWIN WILLIAMS3.8%
Countries (% of fund)
United States100.0%
Sectors (% of fund)
Financials27.4%Information Technology18.4%Industrials15.5%Health Care13.8%Consumer Discretionary9.9%

Listing venues

ESMA register (FIRDS) and official exchange lists
SXRU · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 13 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.blackrock.com/it/investitori-privati/literature/kiid/eu-priips-ish
Factsheet · www.blackrock.com/uk/literature/fact-sheet/csindu-ishares-dow-jones-in
Prospectus · www.blackrock.com/it/investitori-privati/literature/prospectus/ishares
The live sheet, always up to date
rebalix.com/en/etf/IE00B53L4350
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · CIND · IE00B53L43502